SEARCH

SEARCH BY CITATION

References

  • 1
    Haas J, Katus HA, Meder B. Next-generation sequencing entering the clinical arena. Mol Cell Probes. 2011; 25: 206211.
  • 2
    Nelson TJ, Martinez-Fernandez A, Terzic A. Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol. 2010; 7: 700710.
  • 3
    Hewitt RE. Biobanking: the foundation of personalized medicine. Curr Opin Oncol. 2011; 23: 112119.
  • 4
    Moore HM, Compton CC, Alper J, Vaught JB. International approaches to advancing biospecimen science. Cancer Epidemiol Biomarkers Prev. 2011; 20: 729732.
  • 5
    International Society for Biological and Environmental Repositories. Best practices for repositories: collection, storage, retrieval, and distribution of biological materials for research. Biopreserv Biobank. 2012; 10(2): 81161.
  • 6
    Office of Biorepositories and Biospecimen Research, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. NCI Best Practices for Biospecimen Resources 2011: 185. Available at: http://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices.pdf. Accessed August 16, 2012.
  • 7
    Vaught J, Rogers J, Myers K, Lim MD, Lockhart N, Moore H, Sawyer S, Furman JL, Compton C. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr. 2011; 2011(42): 17.
  • 8
    Brisson AR, Matsui D, Rieder MJ, Fraser DD. Translational research in pediatrics: tissue sampling and biobanking. Pediatrics. 2012; 129: 153162.
  • 9
    Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, et al. Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 119: e391e479.
  • 10
    Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996; 94: 28372842.
  • 11
    Yamada KA, Rogers JG, Sundset R, Steinberg TH, Saffitz JE. Upregulation of connexin45 in heart failure. J Cardiovasc Electrophysiol. 2003; 14: 12051212.
  • 12
    Hucker WJ, Fedorov VV, Foyil KV, Moazami N, Efimov IR. Images in cardiovascular medicine: optical mapping of the human atrioventricular junction. Circulation. 2008; 117: 14741477.
  • 13
    Hucker WJ, McCain ML, Laughner JI, Iaizzo PA, Efimov IR. Connexin 43 expression delineates two discrete pathways in the human atrioventricular junction. Anat Rec. 2008; 291: 204215.
  • 14
    Efimov IR, Fedorov VV, Glukhov AV, Lou Q, Ambrosi C, Janks D, Hucker WJ, Kurian T, Schuessler RB, Moazami N. Multiscale imaging of the human heart: building the foundation for human systems physiology and translational medicine. Conf Proc IEEE Eng Med Biol Soc. 2010; 2010: 51705180.
  • 15
    Fedorov VV, Glukhov AV, Chang R, Kostecki G, Aferol H, Hucker WJ, Wuskell JP, Loew LM, Schuessler RB, Moazami N, et al. Optical mapping of the isolated coronary-perfused human sinus node. J Am Coll Cardiol. 2010; 56: 13861394.
  • 16
    Glukhov AV, Fedorov VV, Lou Q, Ravikumar VK, Kalish PW, Schuessler RB, Moazami N, Efimov IR. Transmural dispersion of repolarization in failing and nonfailing human ventricle. Circ Res. 2010; 106: 981991.
  • 17
    Kurian T, Ambrosi C, Hucker W, Fedorov VV, Efimov IR. Anatomy and electrophysiology of the human AV node. Pacing Clin Electrophysiol. 2010; 33: 754762.
  • 18
    Fedorov VV, Glukhov AV, Ambrosi CM, Kostecki G, Chang R, Janks D, Schuessler RB, Moazami N, Nichols CG, Efimov IR. Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol. 2011; 51: 215225.
  • 19
    Lou Q, Fedorov VV, Glukhov AV, Moazami N, Fast VG, Efimov IR. Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure. Circulation. 2011; 123: 18811890.
  • 20
    Glukhov AV, Fedorov VV, Kalish PW, Ravikumar VK, Lou Q, Janks D, Schuessler RB, Moazami N, Efimov IR. Conduction remodeling in human end-stage nonischemic left ventricular cardiomyopathy. Circulation. 2012; 125: 18351847.
  • 21
    Lou Q, Janardhan A, Efimov IR. Remodeling of calcium handling in human heart failure. Adv Exp Med Biol. 2012; 740: 11451174.
  • 22
    Eiseman E, Bloom G, Brower J, Clancy N, Olmsted SS. Case Studies of Existing Human Tissue Repositories. “Best Practices” for a Biospecimen Resource for the Genomic and Proteomic Era. Santa Monica, CA: RAND; 2003.
  • 23
    Pullman D, Etchegary H, Gallagher K, Hodgkinson K, Keough M, Morgan D, Street C. Personal privacy, public benefits, and biobanks: a conjoint analysis of policy priorities and public perceptions. Genet Med. 2012; 14: 229235.
  • 24
    Luque JS, Quinn GP, Montel-Ishino FA, Arevalo M, Bynum SA, Noel-Thomas S, Wells KJ, Gwede CK, Meade CD. Tampa Bay Community Cancer Network Partners: formative research on perceptions of biobanking: what community members think. J Cancer Educ. 2012; 27: 9199.
  • 25
    Saha K, Hurlbut JB. Research ethics: treat donors as partners in biobank research. Nature. 2011; 478: 312313.
  • 26
    Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J. 2007; 30: 373382.
  • 27
    Karp DR, Carlin S, Cook-Deegan R, Ford DE, Geller G, Glass DN, Greely H, Guthridge J, Kahn J, Kaslow R, et al. Ethical and practical issues associated with aggregating databases. PLoS Med. 2008; 5: e190.
  • 28
    Hewitt R, Hainaut P. Biobanking in a fast moving world: an international perspective. J Natl Cancer Inst Monogr. 2011; 2011(42): 5051.
  • 29
    Kiehntopf M, Krawczak M. Biobanking and international interoperability: samples. Hum Genet. 2011; 130: 369376.
  • 30
    Eder J, Gottweis H, Zatloukal K. IT solutions for privacy protection in biobanking. Public Health Genomics. 2012; 15: 254262.
  • 31
    Grizzle WE, Sexton KC, Bell WC. Quality assurance in tissue resources supporting biomedical research. Cell Preserv Technol. 2008; 6: 113118.
  • 32
    Ahsman MJ, Tibboel D, Mathot RA, de Wildt SN. Sample collection, biobanking, and analysis. Handb Exp Pharmacol. 2011; 205: 203217.
  • 33
    Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr. 2011; 42: 2431.
  • 34
    Fullerton SM, Anderson NR, Guzauskas G, Freeman D, Fryer-Edwards K. Meeting the governance challenges of next-generation biorepository research. Sci Transl Med. 2010; 2: 15cm3.
  • 35
    Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, Pearson JV, Stephan DA, Nelson SF, Craig DW. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genetics. 2008; 4: e1000167.
  • 36
    Yang KC, Yamada KA, Patel AY, Topkara VK, Ewald GA, Mann DL, Nerbonne JM. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNA in failing human heart and remodeling with mechanical circulatory support. [Abstract] Circulation. 2012; 126: A15540.